Angiodysplasia cost-effectiveness of therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(6 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Angiodysplasia}}
{{Angiodysplasia}}
{{CMG}} {{AE}} {{NKS}}
{{CMG}}; {{AE}} {{NKT}}


{{PleaseHelp}}
==Angiodysplasia: cost-effectiveness of therapy==
 
Currently, endoscopy is the diagnostic modality of choice, and argon plasma coagulation is the most [[Cost-effectiveness|cost-effective]] endoscopic therapy for bleeding lesions. Pharmacological therapies are also cost-effective for patients with significant co-morbidities who cannot undergo endoscopic therapy.<ref name="pmid17024322">{{cite journal| author=Olmos JA, Marcolongo M, Pogorelsky V, Herrera L, Tobal F, Dávolos JR| title=Long-term outcome of argon plasma ablation therapy for bleeding in 100 consecutive patients with colonic angiodysplasia. | journal=Dis Colon Rectum | year= 2006 | volume= 49 | issue= 10 | pages= 1507-16 | pmid=17024322 | doi=10.1007/s10350-006-0684-1 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17024322  }} </ref><ref name="pmid24138285">{{cite journal| author=Sami SS, Al-Araji SA, Ragunath K| title=Review article: gastrointestinal angiodysplasia - pathogenesis, diagnosis and management. | journal=Aliment Pharmacol Ther | year= 2014 | volume= 39 | issue= 1 | pages= 15-34 | pmid=24138285 | doi=10.1111/apt.12527 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24138285  }} </ref>
==Agiodysplasia cost-effectiveness of therapy==
Currently, endoscopy is the diagnostic modality of choice, and argon plasma coagulation is the most cost-effective endoscopic therapy for the bleeding lesions.


==References==
==References==

Latest revision as of 10:55, 15 October 2021

Angiodysplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Angiodysplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Angiodysplasia cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Angiodysplasia cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Angiodysplasia cost-effectiveness of therapy

CDC on Angiodysplasia cost-effectiveness of therapy

Angiodysplasia cost-effectiveness of therapy in the news

Blogs on Angiodysplasia cost-effectiveness of therapy

Directions to Hospitals Treating Angiodysplasia

Risk calculators and risk factors for Angiodysplasia cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nikita Singh, M.B.B.S.[2]

Angiodysplasia: cost-effectiveness of therapy

Currently, endoscopy is the diagnostic modality of choice, and argon plasma coagulation is the most cost-effective endoscopic therapy for bleeding lesions. Pharmacological therapies are also cost-effective for patients with significant co-morbidities who cannot undergo endoscopic therapy.[1][2]

References

  1. Olmos JA, Marcolongo M, Pogorelsky V, Herrera L, Tobal F, Dávolos JR (2006). "Long-term outcome of argon plasma ablation therapy for bleeding in 100 consecutive patients with colonic angiodysplasia". Dis Colon Rectum. 49 (10): 1507–16. doi:10.1007/s10350-006-0684-1. PMID 17024322.
  2. Sami SS, Al-Araji SA, Ragunath K (2014). "Review article: gastrointestinal angiodysplasia - pathogenesis, diagnosis and management". Aliment Pharmacol Ther. 39 (1): 15–34. doi:10.1111/apt.12527. PMID 24138285.